- Home
- FLXS vs CRGX Comparison
FLXS vs CRGX Comparison
Compare FLXS & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLXS
- CRGX
- Stock Information
- Founded
- FLXS 2001
- CRGX 2021
- Country
- FLXS United States
- CRGX United States
- Employees
- FLXS N/A
- CRGX N/A
- Industry
- FLXS Home Furnishings
- CRGX
- Sector
- FLXS Consumer Discretionary
- CRGX
- Exchange
- FLXS Nasdaq
- CRGX Nasdaq
- Market Cap
- FLXS 175.4M
- CRGX 190.0M
- IPO Year
- FLXS N/A
- CRGX 2023
- Fundamental
- Price
- FLXS $36.51
- CRGX $4.14
- Analyst Decision
- FLXS
- CRGX Hold
- Analyst Count
- FLXS 0
- CRGX 7
- Target Price
- FLXS N/A
- CRGX $4.67
- AVG Volume (30 Days)
- FLXS 19.5K
- CRGX 638.2K
- Earning Date
- FLXS 08-18-2025
- CRGX 08-11-2025
- Dividend Yield
- FLXS 1.81%
- CRGX N/A
- EPS Growth
- FLXS N/A
- CRGX N/A
- EPS
- FLXS 2.55
- CRGX N/A
- Revenue
- FLXS $437,284,000.00
- CRGX N/A
- Revenue This Year
- FLXS $8.34
- CRGX $58.18
- Revenue Next Year
- FLXS $4.01
- CRGX N/A
- P/E Ratio
- FLXS $14.74
- CRGX N/A
- Revenue Growth
- FLXS 7.24
- CRGX N/A
- 52 Week Low
- FLXS $28.81
- CRGX $3.00
- 52 Week High
- FLXS $65.87
- CRGX $25.45
- Technical
- Relative Strength Index (RSI)
- FLXS 62.25
- CRGX 40.21
- Support Level
- FLXS $33.99
- CRGX $4.33
- Resistance Level
- FLXS $37.71
- CRGX $4.36
- Average True Range (ATR)
- FLXS 1.89
- CRGX 0.18
- MACD
- FLXS 0.74
- CRGX -0.04
- Stochastic Oscillator
- FLXS 85.58
- CRGX 8.89
About FLXS Flexsteel Industries Inc.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.